Lipocine Inc. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Lipocine Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Lipocine Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 5.35M shares, a 0.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.35M +32.1K +0.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 5.35M +113K +2.16% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 5.32M -83.2M -94% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 5.32M +81K +1.55% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 5.32M -83.2M -94% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 5.24M -83.3M -94.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 88.5M +11.9K +0.01% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 5.24M -83.1M -94.1% Dec 31, 2022 10-K 2024-03-07
Q3 2022 88.5M +220K +0.25% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 88.5M +208K +0.24% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 88.5M +208K +0.24% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 88.3M +18.3M +26.1% Dec 31, 2021 10-K 2023-03-10
Q3 2021 88.3M +22.6M +34.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 88.3M +26.9M +43.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 88.3M +40.4M +84.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 70M +32.4M +86% Dec 31, 2020 10-K 2022-03-09
Q3 2020 65.7M +40.7M +162% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 61.4M +36.7M +148% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 47.9M +23.3M +94.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 37.7M +15.9M +73.2% Dec 31, 2019 10-K 2021-03-11
Q3 2019 25M +3.69M +17.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 24.7M +3.46M +16.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 24.6M +3.31M +15.6% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 21.7M +467K +2.2% Dec 31, 2018 10-K 2020-03-13
Q3 2018 21.3M +154K +0.73% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 21.3M +683K +3.32% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 21.3M +2M +10.4% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 21.3M +2.81M +15.2% Dec 31, 2017 10-K 2019-03-06
Q3 2017 21.2M +2.93M +16% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 20.6M +2.33M +12.8% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 19.3M +1.01M +5.54% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 18.5M +212K +1.16% Dec 31, 2016 10-K 2018-03-12
Q3 2016 18.3M +9.45K +0.05% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 18.3M +52.2K +0.29% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 18.3M +5.41M +42.1% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 18.3M +5.45M +42.6% Dec 31, 2015 10-K 2017-03-06
Q3 2015 18.2M +5.47M +42.7% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 18.2M +5.43M +42.5% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 12.9M +89.9K +0.71% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 12.8M +132K +1.04% Dec 31, 2014 10-K 2016-03-10
Q3 2014 12.8M +1.83M +16.7% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 12.8M +9.28M +265% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 12.8M +9.26M +265% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 12.7M +8.21M +184% Dec 31, 2013 10-K 2015-03-11
Q3 2013 11M +7.45M +213% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 3.5M Jun 30, 2013 10-Q 2013-07-09
Q1 2013 3.5M Mar 31, 2013 10-Q 2013-04-24
Q4 2012 4.46M +1.46M +48.5% Dec 31, 2012 10-K 2014-03-31
Q3 2012 3.5M Sep 30, 2012 10-Q 2012-10-26
Q4 2011 3M Dec 31, 2011 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.